Your browser doesn't support javascript.
loading
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM.
Sherrod, Charles F; Saberi, Sara; Nassif, Michael E; Claggett, Brian L; Coats, Caroline J; Garcia-Pavia, Pablo; Januzzi, James L; Lewis, Gregory D; Ma, Changsheng; Maron, Martin S; Miao, Zi Michael; Olivotto, Iacopo; Veselka, Josef; Butzner, Michael; Jacoby, Daniel L; Heitner, Stephen B; Kupfer, Stuart; Malik, Fady I; Meng, Lisa; Wohltman, Amy; Spertus, John A.
Affiliation
  • Sherrod CF; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA. Electronic address: csherrod@saint-lukes.org.
  • Saberi S; Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Nassif ME; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
  • Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Coats CJ; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.
  • Garcia-Pavia P; Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Januzzi JL; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA.
  • Lewis GD; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ma C; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Maron MS; Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
  • Miao ZM; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Olivotto I; Meyer Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy.
  • Veselka J; Department of Cardiology, Angiology and Intensive Care, Klinikum Chemnitz gGmbH, Medical Campus Chemnitz of the Technische Universität Dresden, Dresden, Germany.
  • Butzner M; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Jacoby DL; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Heitner SB; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Kupfer S; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Malik FI; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Meng L; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Wohltman A; Cytokinetics, Incorporated, South San Francisco, California, USA.
  • Spertus JA; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
J Am Coll Cardiol ; 2024 Aug 29.
Article in En | MEDLINE | ID: mdl-39217569
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Am Coll Cardiol Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Am Coll Cardiol Year: 2024 Document type: Article Country of publication: Estados Unidos